Nantahala Capital Management, LLC

13D and 13G Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. The latest filing for each security since 12/18/2024, newest first.

Issuer	Symbol	CUSIP	% of Class	Shares	Form	Filed
NeuroOne Medical Technologies Corporation 13G/A NMTC · 64130M209	NMTC	64130M209	2.6%	798,762	13G/A	11/14/2024 Event 9/30/2024
Nantahala Capital Management, LLC			2.6%	798,762
Wilmot B. Harkey			2.6%	798,762
Daniel Mack			2.6%	798,762
Lyra Therapeutics, Inc. 13G/A LYRA · 55234L105	LYRA	55234L105	1.1%	702,106	13G/A	11/14/2024 Event 9/30/2024
Nantahala Capital Management, LLC			1.1%	702,106
Wilmot B. Harkey			1.1%	702,106
Daniel Mack			1.1%	702,106
Luxfer Holdings PLC 13G/A LXFR · G5698W116	LXFR	G5698W116	1.5%	413,950	13G/A	11/14/2024 Event 9/30/2024
Nantahala Capital Management, LLC			1.5%	413,950
Wilmot B. Harkey			1.5%	413,950
Daniel Mack			1.5%	413,950
IMAX Corporation 13G IMAX · 45245E109 Amended under CUSIP 04524E109 on 2/14/2025	IMAX	45245E109	5.3%	2,778,774	13G	11/14/2024 Event 9/30/2024
Nantahala Capital Management, LLC			5.3%	2,778,774
Wilmot B. Harkey			5.3%	2,778,774
Daniel Mack			5.3%	2,778,774